| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 164 | 442,370 | IVE, COST, IVW, AAPL | 13F-HR | 12/19/2024 | 000108514624006074 |
| Q2 2024 | 168 | 436,450 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006073 |
| Q1 2024 | 171 | 421,267 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006072 |
| Q4 2023 | 166 | 389,850 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006071 |
| Q3 2023 | 200 | 385,126 | NXPI calls, IVE, IVW, COST | 13F-HR | 12/19/2024 | 000108514624006070 |
| Q2 2023 | 219 | 397,381 | NXPI calls, IVE, COST, IVW | 13F-HR | 12/19/2024 | 000108514624006069 |
| Q1 2023 | 210 | 339,244 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006068 |
| Q4 2022 | 213 | 328,262 | IVE, AGG, COST, IVW | 13F-HR | 12/19/2024 | 000108514624006067 |
| Q3 2022 | 208 | 304,982 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006066 |
| Q2 2022 | 216 | 320,858 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006065 |
| Q1 2022 | 213 | 424,883 | NXPI calls, IVE, IVW, COST | 13F-HR | 12/19/2024 | 000108514624006064 |
| Q4 2021 | 226 | 424,125 | IVE, IVW, AGG, COST | 13F-HR | 12/19/2024 | 000108514624006062 |
| Q3 2021 | 212 | 403,651 | IVE, IVW, AGG, COST | 13F-HR | 12/19/2024 | 000108514624006061 |
| Q2 2021 | 202 | 411,987 | IVE, IVW, AGG, GVI | 13F-HR | 12/19/2024 | 000108514624006060 |
| Q1 2021 | 188 | 364,074 | IVE, IVW, AGG, GVI | 13F-HR | 12/19/2024 | 000108514624006059 |
| Q4 2020 | 178 | 320,279 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006058 |
| Q3 2020 | 159 | 262,122 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006057 |
| Q2 2020 | 151 | 233,839 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006056 |
| Q1 2020 | 127 | 180,970 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006055 |
| Q4 2019 | 155 | 225,888 | IVE, IVW, ITOT, AGG | 13F-HR | 12/13/2024 | 000108514624006049 |